Home/Pipeline/HROW-638 (SHP-640)

HROW-638 (SHP-640)

Infectious Conjunctivitis

Phase 2/3Active

Key Facts

Indication
Infectious Conjunctivitis
Phase
Phase 2/3
Status
Active
Company

About Harrow Health

Harrow Health is an integrated eyecare company with a mission to address unmet needs in ophthalmology through a diversified business model encompassing proprietary pharmaceuticals, non-sterile compounding, and sterile compounding. The company has achieved commercial success with several FDA-approved products and maintains a pipeline of development-stage candidates. Its strategic direction involves leveraging its ImprimisRx platform for distribution while advancing its proprietary pipeline through internal development and acquisitions.

View full company profile